Hologic, Inc. (LON:0J5Q)

Market Cap	12.29B -6.6%
Revenue (ttm)	3.06B +2.2%
Net Income	403.25M -26.9%
EPS	1.78 -23.8%
Shares Out	n/a
PE Ratio	30.47
Forward PE	16.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	2,368
Open	75.10
Previous Close	75.10
Day's Range	75.10 - 75.16
52-Week Range	51.86 - 75.39
Beta	0.73
RSI	56.59
Earnings Date	Jan 29, 2026

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1985
• Employees: 7,070
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J5Q

Financial Performance

In fiscal year 2025, Hologic's revenue was $4.10 billion, an increase of 1.74% compared to the previous year's $4.03 billion. Earnings were $565.70 million, a decrease of -28.35%.

Financial numbers in USD